+关注
3ded04dd
暂无个人介绍
IP属地:未知
40
关注
2
粉丝
0
主题
0
勋章
主贴
热门
3ded04dd
2021-12-27
[Like]
Japan Joins Coordinated Oil Sales to Combat Rising Prices
3ded04dd
2021-12-27
[Like]
抱歉,原内容已删除
3ded04dd
2021-12-26
[Like]
抱歉,原内容已删除
3ded04dd
2021-12-26
Time to chiong!
3ded04dd
2021-12-25
Time to chiong!
3ded04dd
2021-12-25
[Like] [Like]
COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs
3ded04dd
2021-12-23
Time to buy!
3ded04dd
2021-12-23
👍
抱歉,原内容已删除
3ded04dd
2021-08-27
💪
抱歉,原内容已删除
3ded04dd
2021-08-27
💪
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4092415789566660","uuid":"4092415789566660","gmtCreate":1629313169644,"gmtModify":1640674332728,"name":"3ded04dd","pinyin":"siewdai","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":40,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":696909919,"gmtCreate":1640588287754,"gmtModify":1640588287846,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] ","listText":"[Like] ","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696909919","repostId":"1122841396","repostType":4,"repost":{"id":"1122841396","kind":"news","pubTimestamp":1640582377,"share":"https://www.laohu8.com/m/news/1122841396?lang=&edition=full","pubTime":"2021-12-27 13:19","market":"fut","language":"en","title":"Japan Joins Coordinated Oil Sales to Combat Rising Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1122841396","media":"Bloomberg","summary":"(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat risin","content":"<p>(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s been led by the U.S.</p>\n<p>A government tender offered Oman crude from the strategic reserves in Shibushi for delivery between March and June, the trade ministry said in a statement. The move is part of Japan’s plans to sell oil in coordination with other consuming nations and more sales may follow, according to a ministry official, who declined to be identified because of internal policy.</p>\n<p>The Biden administration started tapping the first of its pledged 50 million barrels of reserves not long after announcing the coordinated release in late November. South Korea said last week that it will start releasing crude and oil products from its strategic reserves next month, although other countries named as part of the plan -- including China and India -- have yet to act.</p>\n<p>The inaugural volume offered by Japan is 100,000 kiloliters, according to a second ministry statement. The ministry plans to announce additional sales, while monitoring the energy markets, the official said.</p>\n<p>At present, there are signs of weakening oil demand in Asia given the rapid spread of the omicron variant of the coronavirus. Brent crude, the global benchmark, traded slightly higher above $76 a barrel on Monday, although it’s down by about 7% since the U.S.-led plan was announced.</p>\n<p>Trade Minister Koichi Hagiuda said in November that Japan would conduct the release as it replaces oil in its stockpiles. While it does that regularly, the schedule has been moved up to support similar actions elsewhere, he added.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan Joins Coordinated Oil Sales to Combat Rising Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan Joins Coordinated Oil Sales to Combat Rising Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 13:19 GMT+8 <a href=https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s ...</p>\n\n<a href=\"https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122841396","content_text":"(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s been led by the U.S.\nA government tender offered Oman crude from the strategic reserves in Shibushi for delivery between March and June, the trade ministry said in a statement. The move is part of Japan’s plans to sell oil in coordination with other consuming nations and more sales may follow, according to a ministry official, who declined to be identified because of internal policy.\nThe Biden administration started tapping the first of its pledged 50 million barrels of reserves not long after announcing the coordinated release in late November. South Korea said last week that it will start releasing crude and oil products from its strategic reserves next month, although other countries named as part of the plan -- including China and India -- have yet to act.\nThe inaugural volume offered by Japan is 100,000 kiloliters, according to a second ministry statement. The ministry plans to announce additional sales, while monitoring the energy markets, the official said.\nAt present, there are signs of weakening oil demand in Asia given the rapid spread of the omicron variant of the coronavirus. Brent crude, the global benchmark, traded slightly higher above $76 a barrel on Monday, although it’s down by about 7% since the U.S.-led plan was announced.\nTrade Minister Koichi Hagiuda said in November that Japan would conduct the release as it replaces oil in its stockpiles. While it does that regularly, the schedule has been moved up to support similar actions elsewhere, he added.","news_type":1,"symbols_score_info":{"BZmain":0.9,"CLmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696900509,"gmtCreate":1640588226294,"gmtModify":1640588226423,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] ","listText":"[Like] ","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696900509","repostId":"1198596552","repostType":4,"isVote":1,"tweetType":1,"viewCount":1998,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698434101,"gmtCreate":1640488632226,"gmtModify":1640488632226,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] ","listText":"[Like] ","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698434101","repostId":"2193781141","repostType":4,"isVote":1,"tweetType":1,"viewCount":2043,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698434934,"gmtCreate":1640488567492,"gmtModify":1640488567492,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"Time to chiong!","listText":"Time to chiong!","text":"Time to chiong!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698434934","isVote":1,"tweetType":1,"viewCount":2225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698226080,"gmtCreate":1640413636095,"gmtModify":1640413636095,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"Time to chiong!","listText":"Time to chiong!","text":"Time to chiong!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698226080","isVote":1,"tweetType":1,"viewCount":1858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698228748,"gmtCreate":1640413587289,"gmtModify":1640413587358,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] [Like] ","listText":"[Like] [Like] ","text":"[Like] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698228748","repostId":"1198358760","repostType":4,"repost":{"id":"1198358760","kind":"news","pubTimestamp":1640396253,"share":"https://www.laohu8.com/m/news/1198358760?lang=&edition=full","pubTime":"2021-12-25 09:37","market":"us","language":"en","title":"COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=1198358760","media":"Seeking Alpha","summary":"The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay ","content":"<ul>\n <li><p>The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay the rebound in MedTech procedures at least through early 2022, a team of analysts from Goldman Sachs argues.</p></li>\n <li>Issuing themes for portfolio set up in healthcare for 2022, the analysts led by Asad Haider warned last week that there could be at least one more COVID-19 wave with the rise of the Omicron variant of the virus.</li>\n <li>Despite the uncertainty over a timeline for the “normalization,” the team sees potential for the disease to reach endemic status in the intermediate term, benefitting certain commercial firms and those leveraged on hospitals and procedures.</li>\n <li>Focusing on the impact of such a scenario on utilization, the analysts turn their attention to MedTech, healthcare provision, and managed care.</li>\n <li>According to them, the resurgence of COVID-19 cases could hurt procedure volumes in H1 2022 and worsen the nursing shortages, which in turn could result in a slowdown in elective procedures and limit the recovery in surgery volumes before subsiding in H2 2022.</li>\n <li>“Expect relative underperformance to continue until at least the Spring, when a resetting of numbers and reduced hospital constraints could foster a recovery,” the analysts Amit Hazan and the team wrote. They predict that there could be more visibility by mid-2022 when “vaccines, natural immunity, antivirals and better overall management experience with Covid should increase the likelihood of recovery.”</li>\n <li>Contrasting its projections in early 2021, the bank avoids modeling “MedTech procedure volumes to rebound to above pre-Covid trend due to pent-up demand or backlog.\" The analysts expect the companies to indicate this in their initial forecasts for next year implying further room for downward revisions in Street forecasts which, according to them, could be the last COVID-induced revision to MedTech estimates.</li>\n <li>Goldman Sachs added Intuitive Surgical(NASDAQ:ISRG)to the firm’s conviction list, citing a potential launch of its multiport system in the first quarter. The maker of da Vinci Surgical System stands alongside Becton Dickinson(NYSE:BDX)and Zimmer Biomet(NYSE:ZBH)as a top large-cap pick in the space. However, the firm is less constructive on Stryker(NYSE:SYK), Medtronic(NYSE:MDT), Edwards Lifesciences(NYSE:EW), and Abbott(NYSE:ABT). See the graph below to compare how some of the above stocks have performed over the past year.</li>\n <li>According to Seeking Alpha Quant Ratings, none of the large-cap MedTech companies, including Abbott (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), and Stryker (SYK), have Bullish prospects. The hospital operator HCA Healthcare(NYSE:HCA)is the only large-cap healthcare provider with a Bullish rating.</li>\n <li>Meanwhile, Goldman Sachs cites a favorable backdrop in managed care space. Despite the ongoing limits to procedure volumes amid labor constraints and shift to low-cost settings, the companies in the subsector are conservatively priced, implying the return of deferred care and COVID costs, the analysts argue.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCOVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 09:37 GMT+8 <a href=https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay the rebound in MedTech procedures at least through early 2022, a team of analysts from Goldman Sachs...</p>\n\n<a href=\"https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198358760","content_text":"The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay the rebound in MedTech procedures at least through early 2022, a team of analysts from Goldman Sachs argues.\nIssuing themes for portfolio set up in healthcare for 2022, the analysts led by Asad Haider warned last week that there could be at least one more COVID-19 wave with the rise of the Omicron variant of the virus.\nDespite the uncertainty over a timeline for the “normalization,” the team sees potential for the disease to reach endemic status in the intermediate term, benefitting certain commercial firms and those leveraged on hospitals and procedures.\nFocusing on the impact of such a scenario on utilization, the analysts turn their attention to MedTech, healthcare provision, and managed care.\nAccording to them, the resurgence of COVID-19 cases could hurt procedure volumes in H1 2022 and worsen the nursing shortages, which in turn could result in a slowdown in elective procedures and limit the recovery in surgery volumes before subsiding in H2 2022.\n“Expect relative underperformance to continue until at least the Spring, when a resetting of numbers and reduced hospital constraints could foster a recovery,” the analysts Amit Hazan and the team wrote. They predict that there could be more visibility by mid-2022 when “vaccines, natural immunity, antivirals and better overall management experience with Covid should increase the likelihood of recovery.”\nContrasting its projections in early 2021, the bank avoids modeling “MedTech procedure volumes to rebound to above pre-Covid trend due to pent-up demand or backlog.\" The analysts expect the companies to indicate this in their initial forecasts for next year implying further room for downward revisions in Street forecasts which, according to them, could be the last COVID-induced revision to MedTech estimates.\nGoldman Sachs added Intuitive Surgical(NASDAQ:ISRG)to the firm’s conviction list, citing a potential launch of its multiport system in the first quarter. The maker of da Vinci Surgical System stands alongside Becton Dickinson(NYSE:BDX)and Zimmer Biomet(NYSE:ZBH)as a top large-cap pick in the space. However, the firm is less constructive on Stryker(NYSE:SYK), Medtronic(NYSE:MDT), Edwards Lifesciences(NYSE:EW), and Abbott(NYSE:ABT). See the graph below to compare how some of the above stocks have performed over the past year.\nAccording to Seeking Alpha Quant Ratings, none of the large-cap MedTech companies, including Abbott (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), and Stryker (SYK), have Bullish prospects. The hospital operator HCA Healthcare(NYSE:HCA)is the only large-cap healthcare provider with a Bullish rating.\nMeanwhile, Goldman Sachs cites a favorable backdrop in managed care space. Despite the ongoing limits to procedure volumes amid labor constraints and shift to low-cost settings, the companies in the subsector are conservatively priced, implying the return of deferred care and COVID costs, the analysts argue.","news_type":1,"symbols_score_info":{"GS":0.9}},"isVote":1,"tweetType":1,"viewCount":1530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691218494,"gmtCreate":1640195245471,"gmtModify":1640195245471,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"Time to buy!","listText":"Time to buy!","text":"Time to buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691218494","isVote":1,"tweetType":1,"viewCount":1368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691218262,"gmtCreate":1640195197886,"gmtModify":1640195197886,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691218262","repostId":"2193194239","repostType":4,"isVote":1,"tweetType":1,"viewCount":2060,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":819184706,"gmtCreate":1630045214005,"gmtModify":1704955102931,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"💪","listText":"💪","text":"💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819184706","repostId":"2162010462","repostType":4,"isVote":1,"tweetType":1,"viewCount":1017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819184568,"gmtCreate":1630045175354,"gmtModify":1704955102758,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"💪","listText":"💪","text":"💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819184568","repostId":"2162010462","repostType":4,"isVote":1,"tweetType":1,"viewCount":814,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":698434101,"gmtCreate":1640488632226,"gmtModify":1640488632226,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] ","listText":"[Like] ","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698434101","repostId":"2193781141","repostType":4,"isVote":1,"tweetType":1,"viewCount":2043,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696900509,"gmtCreate":1640588226294,"gmtModify":1640588226423,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] ","listText":"[Like] ","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696900509","repostId":"1198596552","repostType":4,"repost":{"id":"1198596552","kind":"news","pubTimestamp":1640587950,"share":"https://www.laohu8.com/m/news/1198596552?lang=&edition=full","pubTime":"2021-12-27 14:52","market":"us","language":"en","title":"BlackBerry is a Tough Buy That Will Test Investor Patience","url":"https://stock-news.laohu8.com/highlight/detail?id=1198596552","media":"InvestorPlace","summary":"BB stock will be under pressure while revenue remains elusive","content":"<p><b>BlackBerry</b> (NYSE:<b><u>BB</u></b>) has been under strong selling pressure in the last month. However, the meme stock is still up 38% year-to-date. But with BB stock down 8.9% in the last month and investors getting ready to turn the page on 2021, should speculative investors remain patient while BlackBerry’s business model comes to fruition?</p>\n<p>That’s a tough ask, but that’s different from saying it’s impossible. Right now, BB stock has a couple of long-term catalysts. However, investors looking at its current fundamentals may be scared away.</p>\n<p>Year-over-year revenue for the company’s first two quarters is down 26%. Help could be on the way in the form of revenue that the company intends to receive by selling many of its mobile device patents.</p>\n<p>It’s not surprising that BlackBerry is cutting ties from the namesake mobile device that made the company a household name. However, the emergence of the smartphone ended BlackBerry’s supremacy. Selling off the intellectual property will add some much needed revenue to the bottom-line.</p>\n<p>But the deal has taken some time and based on recent price action, investors are losing patience. Nevertheless, when the company last reported earnings, Chief Executive Officer John Chen said there was an 80% chance that the sale would be completed by the quarter’s end, which will occur in February 2022.</p>\n<p>The larger question, however, is how long investors will have to wait for the company’s other business units to deliver revenue.</p>\n<p><b>BlackBerry’s Future is Also Its Past</b></p>\n<p>I’ve always said I’m old enough to remember when the BlackBerry was a status symbol. But aside from being the precursor to our current smartphone addiction, many people loved the safety and security of their BlackBerry devices.</p>\n<p>This focus on cybersecurity is not just part of BlackBerry’s past, but it’s also a key element of the company’s future. In fact, cybersecurity solutions from BlackBerry QNX accounts for nearly 66% of BlackBerry’s revenue. And the global cybersecurity market is expected to be valued at $345.4 billion by 2026. As it is currently valued at $183.34 billion, that’s an increase of around 88% in the next five years.</p>\n<p>That’s not the only catalyst for BlackBerry. The company is also competing in the autonomous vehicle space with its Intelligent Vehicle Data Platform (IVY). This is a scalable, cloud-connected software program that BlackBerry is offering as a universal solution for connected vehicles. According to BlackBerry, the IVY system delivers on three key objectives.</p>\n<p>First, it accelerates development of “new in-vehicle customer experiences.” It also opens opportunities for connected vehicle manufacturers to expand their community of app developers. And it does all of that while streamlining costs.</p>\n<p>However, the real payoff for IVY won’t take place until automated vehicles become a reality. While analysts may disagree on the exact length of time for that to happen, it’s measured in years, not months.</p>\n<p><b>Analysts Are Sending Mixed Messages</b></p>\n<p>The consensus rating for BB stock is a Sell. However, analysts put the consensus 12-month price target for BlackBerry at $9.40. That’s a $7.67 upside. That means if there is a broader sell-off investors may want to consider buying BlackBerry at around $7.60.</p>\n<p>That would be in-line with the stock’s most recent rating from Paul Treiber of the Royal Bank of Canada. On Dec. 17, Treiber gave the stock an Underperform rating with a $7.50 price target.</p>\n<p>However, after a sharp selloff, BB stock is presenting investors with a potentially bullish technical pattern that may allow the stock to move higher, particularly if it beats expectations when it reports earnings.</p>\n<p><b>Can BB Stock Get it Right?</b></p>\n<p>I don’t currently own BB stock, but it is one of the meme stocks that I find intriguing. That’s because its underlying business plan has potential. However, it’s likely to be several years before that potential is realized. For that reason, I’ll be keeping BlackBerry on my watch list, but I’ll be staying on the sidelines until I hear more.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BlackBerry is a Tough Buy That Will Test Investor Patience</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlackBerry is a Tough Buy That Will Test Investor Patience\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 14:52 GMT+8 <a href=https://investorplace.com/2021/12/bb-stock-is-tough-buy-that-will-test-investor-patience/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BlackBerry (NYSE:BB) has been under strong selling pressure in the last month. However, the meme stock is still up 38% year-to-date. But with BB stock down 8.9% in the last month and investors getting...</p>\n\n<a href=\"https://investorplace.com/2021/12/bb-stock-is-tough-buy-that-will-test-investor-patience/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BB":"黑莓"},"source_url":"https://investorplace.com/2021/12/bb-stock-is-tough-buy-that-will-test-investor-patience/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198596552","content_text":"BlackBerry (NYSE:BB) has been under strong selling pressure in the last month. However, the meme stock is still up 38% year-to-date. But with BB stock down 8.9% in the last month and investors getting ready to turn the page on 2021, should speculative investors remain patient while BlackBerry’s business model comes to fruition?\nThat’s a tough ask, but that’s different from saying it’s impossible. Right now, BB stock has a couple of long-term catalysts. However, investors looking at its current fundamentals may be scared away.\nYear-over-year revenue for the company’s first two quarters is down 26%. Help could be on the way in the form of revenue that the company intends to receive by selling many of its mobile device patents.\nIt’s not surprising that BlackBerry is cutting ties from the namesake mobile device that made the company a household name. However, the emergence of the smartphone ended BlackBerry’s supremacy. Selling off the intellectual property will add some much needed revenue to the bottom-line.\nBut the deal has taken some time and based on recent price action, investors are losing patience. Nevertheless, when the company last reported earnings, Chief Executive Officer John Chen said there was an 80% chance that the sale would be completed by the quarter’s end, which will occur in February 2022.\nThe larger question, however, is how long investors will have to wait for the company’s other business units to deliver revenue.\nBlackBerry’s Future is Also Its Past\nI’ve always said I’m old enough to remember when the BlackBerry was a status symbol. But aside from being the precursor to our current smartphone addiction, many people loved the safety and security of their BlackBerry devices.\nThis focus on cybersecurity is not just part of BlackBerry’s past, but it’s also a key element of the company’s future. In fact, cybersecurity solutions from BlackBerry QNX accounts for nearly 66% of BlackBerry’s revenue. And the global cybersecurity market is expected to be valued at $345.4 billion by 2026. As it is currently valued at $183.34 billion, that’s an increase of around 88% in the next five years.\nThat’s not the only catalyst for BlackBerry. The company is also competing in the autonomous vehicle space with its Intelligent Vehicle Data Platform (IVY). This is a scalable, cloud-connected software program that BlackBerry is offering as a universal solution for connected vehicles. According to BlackBerry, the IVY system delivers on three key objectives.\nFirst, it accelerates development of “new in-vehicle customer experiences.” It also opens opportunities for connected vehicle manufacturers to expand their community of app developers. And it does all of that while streamlining costs.\nHowever, the real payoff for IVY won’t take place until automated vehicles become a reality. While analysts may disagree on the exact length of time for that to happen, it’s measured in years, not months.\nAnalysts Are Sending Mixed Messages\nThe consensus rating for BB stock is a Sell. However, analysts put the consensus 12-month price target for BlackBerry at $9.40. That’s a $7.67 upside. That means if there is a broader sell-off investors may want to consider buying BlackBerry at around $7.60.\nThat would be in-line with the stock’s most recent rating from Paul Treiber of the Royal Bank of Canada. On Dec. 17, Treiber gave the stock an Underperform rating with a $7.50 price target.\nHowever, after a sharp selloff, BB stock is presenting investors with a potentially bullish technical pattern that may allow the stock to move higher, particularly if it beats expectations when it reports earnings.\nCan BB Stock Get it Right?\nI don’t currently own BB stock, but it is one of the meme stocks that I find intriguing. That’s because its underlying business plan has potential. However, it’s likely to be several years before that potential is realized. For that reason, I’ll be keeping BlackBerry on my watch list, but I’ll be staying on the sidelines until I hear more.","news_type":1,"symbols_score_info":{"BB":0.9}},"isVote":1,"tweetType":1,"viewCount":1998,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698228748,"gmtCreate":1640413587289,"gmtModify":1640413587358,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] [Like] ","listText":"[Like] [Like] ","text":"[Like] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698228748","repostId":"1198358760","repostType":4,"repost":{"id":"1198358760","kind":"news","pubTimestamp":1640396253,"share":"https://www.laohu8.com/m/news/1198358760?lang=&edition=full","pubTime":"2021-12-25 09:37","market":"us","language":"en","title":"COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=1198358760","media":"Seeking Alpha","summary":"The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay ","content":"<ul>\n <li><p>The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay the rebound in MedTech procedures at least through early 2022, a team of analysts from Goldman Sachs argues.</p></li>\n <li>Issuing themes for portfolio set up in healthcare for 2022, the analysts led by Asad Haider warned last week that there could be at least one more COVID-19 wave with the rise of the Omicron variant of the virus.</li>\n <li>Despite the uncertainty over a timeline for the “normalization,” the team sees potential for the disease to reach endemic status in the intermediate term, benefitting certain commercial firms and those leveraged on hospitals and procedures.</li>\n <li>Focusing on the impact of such a scenario on utilization, the analysts turn their attention to MedTech, healthcare provision, and managed care.</li>\n <li>According to them, the resurgence of COVID-19 cases could hurt procedure volumes in H1 2022 and worsen the nursing shortages, which in turn could result in a slowdown in elective procedures and limit the recovery in surgery volumes before subsiding in H2 2022.</li>\n <li>“Expect relative underperformance to continue until at least the Spring, when a resetting of numbers and reduced hospital constraints could foster a recovery,” the analysts Amit Hazan and the team wrote. They predict that there could be more visibility by mid-2022 when “vaccines, natural immunity, antivirals and better overall management experience with Covid should increase the likelihood of recovery.”</li>\n <li>Contrasting its projections in early 2021, the bank avoids modeling “MedTech procedure volumes to rebound to above pre-Covid trend due to pent-up demand or backlog.\" The analysts expect the companies to indicate this in their initial forecasts for next year implying further room for downward revisions in Street forecasts which, according to them, could be the last COVID-induced revision to MedTech estimates.</li>\n <li>Goldman Sachs added Intuitive Surgical(NASDAQ:ISRG)to the firm’s conviction list, citing a potential launch of its multiport system in the first quarter. The maker of da Vinci Surgical System stands alongside Becton Dickinson(NYSE:BDX)and Zimmer Biomet(NYSE:ZBH)as a top large-cap pick in the space. However, the firm is less constructive on Stryker(NYSE:SYK), Medtronic(NYSE:MDT), Edwards Lifesciences(NYSE:EW), and Abbott(NYSE:ABT). See the graph below to compare how some of the above stocks have performed over the past year.</li>\n <li>According to Seeking Alpha Quant Ratings, none of the large-cap MedTech companies, including Abbott (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), and Stryker (SYK), have Bullish prospects. The hospital operator HCA Healthcare(NYSE:HCA)is the only large-cap healthcare provider with a Bullish rating.</li>\n <li>Meanwhile, Goldman Sachs cites a favorable backdrop in managed care space. Despite the ongoing limits to procedure volumes amid labor constraints and shift to low-cost settings, the companies in the subsector are conservatively priced, implying the return of deferred care and COVID costs, the analysts argue.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCOVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 09:37 GMT+8 <a href=https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay the rebound in MedTech procedures at least through early 2022, a team of analysts from Goldman Sachs...</p>\n\n<a href=\"https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198358760","content_text":"The ongoing resurgence of the pandemic could limit recovery in hospital procedure volumes and delay the rebound in MedTech procedures at least through early 2022, a team of analysts from Goldman Sachs argues.\nIssuing themes for portfolio set up in healthcare for 2022, the analysts led by Asad Haider warned last week that there could be at least one more COVID-19 wave with the rise of the Omicron variant of the virus.\nDespite the uncertainty over a timeline for the “normalization,” the team sees potential for the disease to reach endemic status in the intermediate term, benefitting certain commercial firms and those leveraged on hospitals and procedures.\nFocusing on the impact of such a scenario on utilization, the analysts turn their attention to MedTech, healthcare provision, and managed care.\nAccording to them, the resurgence of COVID-19 cases could hurt procedure volumes in H1 2022 and worsen the nursing shortages, which in turn could result in a slowdown in elective procedures and limit the recovery in surgery volumes before subsiding in H2 2022.\n“Expect relative underperformance to continue until at least the Spring, when a resetting of numbers and reduced hospital constraints could foster a recovery,” the analysts Amit Hazan and the team wrote. They predict that there could be more visibility by mid-2022 when “vaccines, natural immunity, antivirals and better overall management experience with Covid should increase the likelihood of recovery.”\nContrasting its projections in early 2021, the bank avoids modeling “MedTech procedure volumes to rebound to above pre-Covid trend due to pent-up demand or backlog.\" The analysts expect the companies to indicate this in their initial forecasts for next year implying further room for downward revisions in Street forecasts which, according to them, could be the last COVID-induced revision to MedTech estimates.\nGoldman Sachs added Intuitive Surgical(NASDAQ:ISRG)to the firm’s conviction list, citing a potential launch of its multiport system in the first quarter. The maker of da Vinci Surgical System stands alongside Becton Dickinson(NYSE:BDX)and Zimmer Biomet(NYSE:ZBH)as a top large-cap pick in the space. However, the firm is less constructive on Stryker(NYSE:SYK), Medtronic(NYSE:MDT), Edwards Lifesciences(NYSE:EW), and Abbott(NYSE:ABT). See the graph below to compare how some of the above stocks have performed over the past year.\nAccording to Seeking Alpha Quant Ratings, none of the large-cap MedTech companies, including Abbott (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), and Stryker (SYK), have Bullish prospects. The hospital operator HCA Healthcare(NYSE:HCA)is the only large-cap healthcare provider with a Bullish rating.\nMeanwhile, Goldman Sachs cites a favorable backdrop in managed care space. Despite the ongoing limits to procedure volumes amid labor constraints and shift to low-cost settings, the companies in the subsector are conservatively priced, implying the return of deferred care and COVID costs, the analysts argue.","news_type":1,"symbols_score_info":{"GS":0.9}},"isVote":1,"tweetType":1,"viewCount":1530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691218262,"gmtCreate":1640195197886,"gmtModify":1640195197886,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691218262","repostId":"2193194239","repostType":4,"isVote":1,"tweetType":1,"viewCount":2060,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696909919,"gmtCreate":1640588287754,"gmtModify":1640588287846,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"[Like] ","listText":"[Like] ","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696909919","repostId":"1122841396","repostType":4,"repost":{"id":"1122841396","kind":"news","pubTimestamp":1640582377,"share":"https://www.laohu8.com/m/news/1122841396?lang=&edition=full","pubTime":"2021-12-27 13:19","market":"fut","language":"en","title":"Japan Joins Coordinated Oil Sales to Combat Rising Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1122841396","media":"Bloomberg","summary":"(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat risin","content":"<p>(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s been led by the U.S.</p>\n<p>A government tender offered Oman crude from the strategic reserves in Shibushi for delivery between March and June, the trade ministry said in a statement. The move is part of Japan’s plans to sell oil in coordination with other consuming nations and more sales may follow, according to a ministry official, who declined to be identified because of internal policy.</p>\n<p>The Biden administration started tapping the first of its pledged 50 million barrels of reserves not long after announcing the coordinated release in late November. South Korea said last week that it will start releasing crude and oil products from its strategic reserves next month, although other countries named as part of the plan -- including China and India -- have yet to act.</p>\n<p>The inaugural volume offered by Japan is 100,000 kiloliters, according to a second ministry statement. The ministry plans to announce additional sales, while monitoring the energy markets, the official said.</p>\n<p>At present, there are signs of weakening oil demand in Asia given the rapid spread of the omicron variant of the coronavirus. Brent crude, the global benchmark, traded slightly higher above $76 a barrel on Monday, although it’s down by about 7% since the U.S.-led plan was announced.</p>\n<p>Trade Minister Koichi Hagiuda said in November that Japan would conduct the release as it replaces oil in its stockpiles. While it does that regularly, the schedule has been moved up to support similar actions elsewhere, he added.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan Joins Coordinated Oil Sales to Combat Rising Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan Joins Coordinated Oil Sales to Combat Rising Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 13:19 GMT+8 <a href=https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s ...</p>\n\n<a href=\"https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122841396","content_text":"(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s been led by the U.S.\nA government tender offered Oman crude from the strategic reserves in Shibushi for delivery between March and June, the trade ministry said in a statement. The move is part of Japan’s plans to sell oil in coordination with other consuming nations and more sales may follow, according to a ministry official, who declined to be identified because of internal policy.\nThe Biden administration started tapping the first of its pledged 50 million barrels of reserves not long after announcing the coordinated release in late November. South Korea said last week that it will start releasing crude and oil products from its strategic reserves next month, although other countries named as part of the plan -- including China and India -- have yet to act.\nThe inaugural volume offered by Japan is 100,000 kiloliters, according to a second ministry statement. The ministry plans to announce additional sales, while monitoring the energy markets, the official said.\nAt present, there are signs of weakening oil demand in Asia given the rapid spread of the omicron variant of the coronavirus. Brent crude, the global benchmark, traded slightly higher above $76 a barrel on Monday, although it’s down by about 7% since the U.S.-led plan was announced.\nTrade Minister Koichi Hagiuda said in November that Japan would conduct the release as it replaces oil in its stockpiles. While it does that regularly, the schedule has been moved up to support similar actions elsewhere, he added.","news_type":1,"symbols_score_info":{"BZmain":0.9,"CLmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698434934,"gmtCreate":1640488567492,"gmtModify":1640488567492,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"Time to chiong!","listText":"Time to chiong!","text":"Time to chiong!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698434934","isVote":1,"tweetType":1,"viewCount":2225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698226080,"gmtCreate":1640413636095,"gmtModify":1640413636095,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"Time to chiong!","listText":"Time to chiong!","text":"Time to chiong!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698226080","isVote":1,"tweetType":1,"viewCount":1858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691218494,"gmtCreate":1640195245471,"gmtModify":1640195245471,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"Time to buy!","listText":"Time to buy!","text":"Time to buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691218494","isVote":1,"tweetType":1,"viewCount":1368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":819184706,"gmtCreate":1630045214005,"gmtModify":1704955102931,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"💪","listText":"💪","text":"💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819184706","repostId":"2162010462","repostType":4,"isVote":1,"tweetType":1,"viewCount":1017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819184568,"gmtCreate":1630045175354,"gmtModify":1704955102758,"author":{"id":"4092415789566660","authorId":"4092415789566660","name":"3ded04dd","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092415789566660","authorIdStr":"4092415789566660"},"themes":[],"htmlText":"💪","listText":"💪","text":"💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819184568","repostId":"2162010462","repostType":4,"isVote":1,"tweetType":1,"viewCount":814,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}